# EDGAR Filing Document

**Accession Number:** 0001822947
**File Stem:** 0001021408-25-004691
**Filing Date:** 2025-8
**Character Count:** 25527
**Document Hash:** 779286c30c91649ffce7cf3b416e70b7
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001021408-25-004691.hdr.sgml**: 20250829

**ACCESSION NUMBER**: 0001021408-25-004691

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250829

**EFFECTIVENESS DATE**: 20250829

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Ally Bridge Group (NY) LLC
- **CENTRAL INDEX KEY:** 0001822947

**ORGANIZATION NAME:**
- **EIN:** 352593330
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-20834
- **FILM NUMBER:** 251281475

**BUSINESS ADDRESS:**
- **STREET 1:** 430 PARK AVENUE, 12TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022
- **BUSINESS PHONE:** 6468299830

**MAIL ADDRESS:**
- **STREET 1:** 430 PARK AVENUE, 12TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10022

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001822947

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** Ally Bridge Group (NY) LLC

**Address:** 430 Park Avenue, 12th Floor, New York, NY 10022

**Telephone number:** 646-809-3771

**Name of agent for service:** —

**Agent Address:** —, —, — —

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-20834

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [ ] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [x] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER                   | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| AADI BIOSCIENCE, INC.            | 00032Q104 | 2/28/2025      | Non-Binding Advisory Vote on Golden Parachutes Proposal: To approve, on a non-binding, advisory basis, certain compensation that will or may become payable to our named executive officers in connection with the Divestiture.                                                                                                                                                                                                                                                                                                | SECTION 14A SAY-ON-PAY VOTES |         754148 |            63791 | FOR         |                                   754148 | FOR                         |  |
| ATYR PHARMA, INC                 | 002120202 | 5/1/2025       | To approve, on an advisory basis, the compensation of the Company's named executive officers;                                                                                                                                                                                                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |         582230 |                0 | FOR         |                                   582230 | FOR                         |  |
| VERONA PHARMA PLC                | 925050106 | 4/24/2025      | To approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |         138317 |                0 | FOR         |                                   138317 | FOR                         |  |
| SPRINGWORKS THERAPEUTICS INC     | 85205L107 | 5/14/2025      | Non-binding advisory vote on executive compensation                                                                                                                                                                                                                                                                                                                                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |         206353 |            39786 | FOR         |                                   206353 | FOR                         |  |
| INSMED INCORPORATED              | 457669307 | 5/15/2025      | An advisory vote on the 2024 compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |          70277 |            42583 | FOR         |                                    70277 | FOR                         |  |
| GERON CORPORATION                | 374163103 | 5/21/2025      | To approve, on an advisory basis, the compensation of our Named Executive Officers, as disclosed in our Proxy Statement.                                                                                                                                                                                                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |        1244117 |          1207520 | FOR         |                                  1244117 | FOR                         |  |
| DIANTHUS THERAPEUTICS, INC.      | 252828108 | 5/22/2025      | To approve, on an advisory basis, the compensation paid to our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |          27190 |            53394 | FOR         |                                    27190 | FOR                         |  |
| TREVI THERAPEUTICS INC           | 89532M101 | 6/11/2025      | Approval, on an advisory basis, of the compensation paid to our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         740885 |                0 | FOR         |                                   740885 | FOR                         |  |
| TREVI THERAPEUTICS INC           | 89532M101 | 6/11/2025      | Approval, on an advisory basis, of the frequency of future advisory votes to approve the compensation paid to our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |         740885 |                0 | FOR         |                                   740885 | FOR                         |  |
| XENON PHARMACEUTICALS INC        | 98420N105 | 6/4/2025       | To approve, on an advisory basis, the compensation of the Corporation's named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |          69603 |                0 | FOR         |                                    69603 | FOR                         |  |
| BLUEPRINT MEDICINES CORPORATION  | 09627Y109 | 6/18/2025      | Approval of a non-binding advisory vote on the compensation paid to our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                              | SECTION 14A SAY-ON-PAY VOTES |         104692 |                0 | FOR         |                                   104692 | FOR                         |  |
| MERUS N.V.                       | N5749R100 | 5/21/2025      | Approval, on an advisory (non-binding) basis, of the compensation of Merus N.V.'s named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |          83896 |                0 | FOR         |                                    83896 | FOR                         |  |
| AXSOME THERAPEUTICS, INC.        | 05464T104 | 6/6/2025       | To approve, by non-binding advisory vote, the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |          30950 |            23999 | FOR         |                                    30950 | FOR                         |  |
| TECTONIC THERAPEUTIC, INC        | 878972108 | 6/5/2025       | Advisory approval of the compensation of the Company's Named Executive Officers.                                                                                                                                                                                                                                                                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |         123811 |             8411 | FOR         |                                   123811 | FOR                         |  |
| TECTONIC THERAPEUTIC, INC        | 878972108 | 6/5/2025       | Advisory vote on the frequency of stockholder advisory votes on executive compensation.                                                                                                                                                                                                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |         123811 |             8411 | FOR         |                                   123811 | FOR                         |  |
| JANUX THERAPEUTICS, INC.         | 47103J105 | 6/11/2025      | Approval, on an advisory basis, of the compensation of our named executive officers ("Say-On-Pay"), as disclosed in the accompanying Proxy Statement.                                                                                                                                                                                                                                                                                                                                                                          | SECTION 14A SAY-ON-PAY VOTES |          81292 |                0 | FOR         |                                    81292 | FOR                         |  |
| JANUX THERAPEUTICS, INC.         | 47103J105 | 6/11/2025      | Indication, on an advisory basis, of the preferred frequency of holding future Say-On-Pay votes on the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |          81292 |                0 | FOR         |                                    81292 | FOR                         |  |
| PRAXIS PRECISION MEDICINES, INC. | 74006W207 | 6/26/2025      | To approve, on an advisory (non-binding) basis, the compensation of the named executive officers as disclosed in the Company's proxy statement for the 2025 Annual Meeting of Stockholders pursuant to the applicable compensation disclosure rules of the SEC, including the compensation tables and narrative discussion.                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |          74327 |            21255 | FOR         |                                    74327 | FOR                         |  |
| TARSUS PHARMACEUTICALS, INC.     | 87650L103 | 6/12/2025      | To hold an advisory vote to approve, on a non-binding basis, named executive officer compensation.                                                                                                                                                                                                                                                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |          77378 |            56554 | FOR         |                                    77378 | FOR                         |  |
| TARSUS PHARMACEUTICALS, INC.     | 87650L103 | 6/12/2025      | To hold an advisory vote to approve, on a non-binding basis, the frequency with which future stockholder votes on the compensation of our named executive officers will be conducted of one, two or three years.                                                                                                                                                                                                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |          77378 |            56554 | FOR         |                                    77378 | FOR                         |  |
| EDGEWISE THERAPEUTICS INC        | 28036F105 | 6/13/2025      | Conduct an advisory vote on the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |         232650 |                0 | FOR         |                                   232650 | FOR                         |  |
| EDGEWISE THERAPEUTICS INC        | 28036F105 | 6/13/2025      | Conduct an advisory vote on the frequency of future advisory votes on the compensation of our named executive officers.                                                                                                                                                                                                                                                                                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |         232650 |                0 | FOR         |                                   232650 | FOR                         |  |
| KORRO BIO, INC.                  | 500946108 | 6/11/2025      | Non-Binding Advisory Vote to Approve the Compensation of our Named Executive Officers.                                                                                                                                                                                                                                                                                                                                                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |          59723 |                0 | FOR         |                                    59723 | FOR                         |  |
| KORRO BIO, INC.                  | 500946108 | 6/11/2025      | Non-Binding Advisory Vote on the Frequency of Future Non-Binding Advisory Votes to Approve the Compensation of our Named Executive Officers                                                                                                                                                                                                                                                                                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |          59723 |                0 | FOR         |                                    59723 | FOR                         |  |
| WHITEHAWK THERAPEUTICS, INC.     | 00032Q104 | 6/11/2025      | To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the 'Executive Compensation' section of the proxy statement.                                                                                                                                                                                                                                                                                                                           | SECTION 14A SAY-ON-PAY VOTES |         434982 |           382957 | FOR         |                                   434982 | FOR                         |  |
| CENTESSA PHARMACEUTICALS PLC     | 152309100 | 6/12/2025      | To receive and approve the Directors' Remuneration Policy as set out on pages A-3 to A-25 of the Company's UK statutory directors' remuneration report for the financial year ended December 31, 2024, which is set forth as Annex A to the attached proxy statement, which will take effect immediately after the end of the AGM.                                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         243086 |                0 | FOR         |                                   243086 | FOR                         |  |
| CENTESSA PHARMACEUTICALS PLC     | 152309100 | 6/12/2025      | To generally and unconditionally authorise the directors of the Company or any duly authorised committee of the directors, in accordance with section 551 of the UK Companies Act 2006 (the "Companies Act"), to allot shares in the Company or grant rights to subscribe for or to convert any security into shares in the Company ("Rights") up to an aggregate nominal amount of £133,184 for a period expiring (unless previously renewed, varied or ...(due to space limits, see proxy material for full proposal).       | SECTION 14A SAY-ON-PAY VOTES |         243086 |                0 | FOR         |                                   243086 | FOR                         |  |
| CENTESSA PHARMACEUTICALS PLC     | 152309100 | 6/12/2025      | To generally empower, conditional upon resolution 9 above being duly passed and pursuant to section 570 of the Companies Act, the directors of the Company or any duly authorised committee of the directors to allot equity securities (within the meaning of the Companies Act) for cash pursuant to the authority conferred on them by resolution 9 as if section 561 of the Companies Act and any pre-emption provisions in the articles of association of ...(due to space limits, see proxy material for full proposal). | SECTION 14A SAY-ON-PAY VOTES |         243086 |                0 | FOR         |                                   243086 | FOR                         |  |
| MONOPAR THERAPEUTICS, INC.       | 61023L207 | 6/17/2025      | To approve the compensation of our named executive officers on an advisory, non-binding basis.                                                                                                                                                                                                                                                                                                                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |          34537 |                0 | FOR         |                                    34537 | FOR                         |  |
| MONOPAR THERAPEUTICS, INC.       | 61023L207 | 6/17/2025      | To approve the frequency of future advisory votes on the compensation of our named executive officers on an advisory, non-binding basis.                                                                                                                                                                                                                                                                                                                                                                                       | SECTION 14A SAY-ON-PAY VOTES |          34537 |                0 | FOR         |                                    34537 | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** Ally Bridge Group (NY) LLC

**By (Signature):** Fan Yu

**By (Printed Signature):** Fan Yu

**By (Title):** Director

**Date:** 08/29/2025